載入...
Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer
Tumors often contain hypoxic regions resistant to chemo- and radiotherapy. TH-302 (T) is an investigational hypoxia-activated prodrug that selectively releases the DNA cross-linker bromo-isophosphoramide mustard under hypoxic conditions. This study evaluated the efficacy and safety profile of combin...
Na minha lista:
| 發表在: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4623012/ https://ncbi.nlm.nih.gov/pubmed/25679067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2014.1003005 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|